Marksans Pharma Stock (NSE:MARKSANS)

INDIA |NSE |INR

Price
INR 58.80
Change
1.03%
Today's Range
INR58.05 - INR61.65
52-Week Range
INR43.55 - INR97.26
Market Cap
INR20.08B
Volume
3.86M

About Marksans Pharma (NSE:MARKSANS)

(NSE:MARKSANS) Marksans Pharma Limited, together with its subsidiaries, researches, develops, manufactures, markets, distributes, and sells generic pharmaceutical formulations in North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the analgesic, anti-inflammatory, benign prostatic hyperplasia, epilepsy, hyperparathyroidism, diabetic and antidiabetic, pain management, neurology, antacid, hormonal, antifungal, antiulcerative, cardiovascular and central nervous system, vitamin, cough and cold, dermatology, gastrointestinal, gynecology, cephalosporin, injectable, antibacterial, hypertension, oncology, and antibiotics and anti-allergic therapeutic areas. It also provides contract research and manufacturing services; and develops and out-licenses patented products. The company was incorporated in 1992 and is headquartered in Mumbai, India.
Show more

MARKSANS Stock Price

Statistics Highlights (NSE:MARKSANS)

Shares Outstanding 409.31M Beta 1.36
Public Float 197.65M P/E Ratio 8.42
% Short of Float - Dividend (Yield) -
Held by Insiders 49.62% Ex-Dividend Date Sep 15, 2021
Held by Institutions 2.31% IPO Date -

MARKSANS Financial Summary

|
Mar 21 Mar 20 Mar 19
Revenue INR13.68B INR11.29B INR9.87B
EBITDA INR3.42B INR1.89B INR1.33B
Net Income INR2.39B INR1.21B INR804.37M
Total Assets INR12.28B INR8.97B INR8.04B
Total Cash INR2.09B INR931.21M INR328.55M
Total Debt INR341.02M INR296.50M INR1.00B
Dec 21 Sep 21 Jun 21
Revenue INR3.63B INR3.61B INR3.49B
EBITDA INR698.60M INR686.65M INR832.21M
Net Income INR482.72M INR454.91M INR626.00M
Total Assets INR INR14.07B INR
Total Cash INR INR3.23B INR
Total Debt INR INR80.58M INR

MARKSANS Stock Price History

Marksans Pharma Annual Stock Price History

Year Open Close Change
2021 INR59.10 INR58.80 -0.51%
2021 INR61.00 INR59.10 -3.11%
2020 INR16.80 INR61.00 263.10%

Marksans Pharma Daily Stock Price History

Date Open High Low Close Change Volume
Jun 27, 2022 INR42.25 INR42.85 INR41.80 INR42.05 -7.68% 488.55K
Jun 8, 2022 INR46.20 INR46.40 INR45.45 INR45.55 2.24% 493.29K
Jun 14, 2022 INR44.95 INR46.20 INR44.00 INR44.55 12.93% 581.62K

(NSE:MARKSANS) Stock Price FAQs

What is today's stock price of Marksans Pharma (NSE:MARKSANS)?

  • The current stock price of Marksans Pharma (NSE:MARKSANS) is INR58.80.
  • Today MARKSANS stock price opened at INR58.05 after previous close of INR58.20.
  • During the day, Marksans Pharma stock quote has varied from a low of INR58.05 to a high of INR61.65.

What is Marksans Pharma's 52-week change?

  • MARKSANS 52-week high stock quote is INR97.26, which is 65.40% above the current share price.
  • The Marksans Pharma (NSE:MARKSANS) 52-week low stock price is INR43.55, which is 25.90% below the current share price.
  • Marksans Pharma share price volatility (52-week beta) is 1.36.

Marksans Pharma (NSE:MARKSANS) FAQ

How Much is Marksans pharma Worth?

Marksans pharma's worth today based on market capitalisation is INR20.08B

How much dividend does Marksans pharma Pay?

The current annualized dividend payout for MARKSANS stock is INR0.25, the dividend yield is 0.50% and the payout ratio is 4.30%.
View More Details on Marksans pharma's "Dividend" Section

What is Marksans pharma’s Price to Earning (PE) ratio?

Marksans pharma has a Price to Earning (P/E) ratio of 8.42. MARKSANS stock also has a Price to Sales (P/S) ratio of 1.40.

What is the Marksans pharma's ticker?

Marksans pharma trades on the NSE stock market in India under the ticker symbol "MARKSANS". Marksans pharma’s stock symbol can also be displayed as "NSE:MARKSANS".

Who are the owners of Marksans pharma?

Marksans pharma (NSE:MARKSANS) is owned by 2.31% institutional shareholders and by 49.62% insiders. The rest is owned by the public.
Explore More Details on Marksans pharma's “Ownership” Section

Who are the key executives of Marksans pharma (MARKSANS)?

Marksans pharma's key executive team includes the following managers:

  • Mr. Mark B. Saldanha, Non-Independent Exec. Chairman, MD & CEO (1972)
  • Mr. Jitendra M. Sharma, Chief Financial Officer (1969)
  • Mr. Supratika Tripathi, Director of Operations (NA)
  • Mr. Harshavardhan Panigrahi, Company Sec., Mang. of Legal & Compliance Officer (NA)
  • Ms. Sandra Saldanha, Exec. Non-Independent Director (1971)
  • Mr. Varddhman Vikramaditya Jain, Exec. & Non-Independent Director (1970)
  • Mr. Sunil K. Rane, Sr. VP of QC (1969)
  • Mr. Sopan Pisal, Director of QA (1971)
  • Mr. Sridhar Naidu, Gen. Mang. of HR & Admin (1979)
  • Mr. Umesh Rivankar, Head of Domestic Marketing (NA)

What is Marksans pharma’s Sector & Industry Classification?

Marksans pharma (NSE:MARKSANS) is classified under the "Healthcare" sector and under the "Drug Manufacturers-General" industry.

How many employees work for Marksans pharma?

Currently the number of employees working for Marksans pharma is 1,138.

Where are Marksans pharma's Headquarters?

Marksans pharma (NSE:MARKSANS) is headquartered in India.

What are Marksans pharma's Address and Phone Number?

Marksans pharma’s mailing address is Grandeur, Mumbai, India, 400053.
The company’s phone number is 91 22 4001 2000.

What is the official website for Marksans pharma?

Marksans pharma’s official website is http://www.marksanspharma.com